HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,810,644 | +67.6% | 42,539 | +59.3% | 0.02% | +50.0% |
Q2 2023 | $2,273,749 | -31.7% | 26,706 | -33.6% | 0.01% | -33.3% |
Q1 2023 | $3,327,874 | +65332.0% | 40,216 | -37.8% | 0.02% | -37.5% |
Q4 2022 | $5,086 | +3.1% | 64,668 | -3.0% | 0.02% | 0.0% |
Q3 2022 | $4,935 | -99.9% | 66,661 | +11.1% | 0.02% | +33.3% |
Q2 2022 | $3,911,000 | +21.8% | 60,000 | +32.0% | 0.02% | +38.5% |
Q3 2021 | $3,210,000 | +48.5% | 45,471 | +83.5% | 0.01% | +30.0% |
Q3 2020 | $2,162,000 | -46.1% | 24,779 | -44.7% | 0.01% | -50.0% |
Q2 2020 | $4,010,000 | -41.2% | 44,779 | -34.6% | 0.02% | -47.4% |
Q1 2020 | $6,820,000 | +65.9% | 68,436 | +91.3% | 0.04% | +111.1% |
Q4 2019 | $4,111,000 | -51.1% | 35,777 | -46.3% | 0.02% | -53.8% |
Q3 2019 | $8,410,000 | +10.1% | 66,675 | +5.1% | 0.04% | +2.6% |
Q2 2019 | $7,637,000 | +333.7% | 63,458 | +215.2% | 0.04% | +322.2% |
Q1 2019 | $1,761,000 | -41.6% | 20,134 | -33.2% | 0.01% | -43.8% |
Q4 2018 | $3,015,000 | -10.9% | 30,134 | +2.0% | 0.02% | 0.0% |
Q3 2018 | $3,384,000 | +24.3% | 29,535 | -20.6% | 0.02% | +14.3% |
Q1 2018 | $2,723,000 | +14.0% | 37,220 | -9.5% | 0.01% | +27.3% |
Q4 2017 | $2,389,000 | +16.8% | 41,128 | -9.8% | 0.01% | +10.0% |
Q3 2017 | $2,046,000 | +6.8% | 45,606 | -5.9% | 0.01% | +11.1% |
Q2 2017 | $1,915,000 | -2.6% | 48,488 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $1,967,000 | +18.9% | 48,488 | +17.8% | 0.01% | 0.0% |
Q4 2016 | $1,655,000 | +11.0% | 41,170 | 0.0% | 0.01% | +28.6% |
Q3 2016 | $1,491,000 | +24.9% | 41,170 | 0.0% | 0.01% | +16.7% |
Q2 2016 | $1,194,000 | -17.1% | 41,170 | 0.0% | 0.01% | -25.0% |
Q1 2016 | $1,440,000 | +11.1% | 41,170 | +2.4% | 0.01% | 0.0% |
Q4 2015 | $1,296,000 | -22.1% | 40,200 | 0.0% | 0.01% | -11.1% |
Q2 2015 | $1,663,000 | -7.9% | 40,200 | 0.0% | 0.01% | -10.0% |
Q1 2015 | $1,806,000 | +20.1% | 40,200 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $1,504,000 | -3.7% | 40,200 | -10.1% | 0.01% | -11.1% |
Q3 2014 | $1,561,000 | -1.0% | 44,700 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $1,577,000 | +4.1% | 44,700 | -3.9% | 0.01% | 0.0% |
Q1 2014 | $1,515,000 | -32.9% | 46,500 | -13.2% | 0.01% | -30.8% |
Q4 2013 | $2,258,000 | +4.4% | 53,600 | -1.1% | 0.01% | 0.0% |
Q3 2013 | $2,162,000 | – | 54,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |